Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

BRG1-mediated suppression of ferroptosis underlies BTK inhibitor resistance.

Nature communications·2026

Same author

Long-term clinical outcomes from the smart start trial: rituximab, lenalidomide and ibrutinib in patients with newly diagnosed large B-cell lymphoma.

Blood cancer journal·2026

Same author

Mantle cell lymphoma outcomes following sequential first-line bendamustine-rituximab and second-line Bruton's tyrosine kinase inhibitor therapy.

Blood cancer journal·2026

Same author

Correction: Exploiting PRMT5 as a target for combination therapy in mantle cell lymphoma characterized by frequent ATM and TP53 mutations.

Blood cancer journal·2026

Same author

Benefit of rituximab maintenance after first-line bendamustine-rituximab in patients with mantle cell lymphoma.

Blood advances·2026

Same author

Benefit of rituximab maintenance after first-line bendamustine-rituximab in patients with mantle cell lymphoma.

Blood advances·2025

Same journal

Posttreatment ⁶⁸Ga-FAP-2286 PET/CT Parameters for Response and Survival Assessment After ¹⁷⁷Lu-FAP-2286 Radioligand Therapy in Advanced Solid Tumors.

Clinical nuclear medicine·2026

Same journal

18F-FDG PET/CT Imaging of Multiple Inflammatory Myofibroblastic Tumors.

Clinical nuclear medicine·2026

Same journal

Intense Incidental F-18 DOPA Uptake in Low-grade Prostate Adenocarcinoma: A Potential Diagnostic Pitfall.

Clinical nuclear medicine·2026

Same journal

A Prospective Head-to-Head Comparison of HER2-Targeted and 18F-FDG PET/CT for Detecting Axillary Lymph Node Metastases Among Newly Diagnosed HER2-Positive and HER2-Low Breast Cancer.

Clinical nuclear medicine·2026

Same journal

Epileptogenic Brain Metastasis Early Positive on 18FDG PET/CT Compared to MRI.

Clinical nuclear medicine·2026

Same journal

Dural Manifestation of Langerhans Cell Histiocytosis: Multimodality Imaging Approach.

Clinical nuclear medicine·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Mar 9, 2026

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

FDG PET/CT in Malignant Eccrine Spiradenoma.

Gabriela Sanchez Petitto¹, Nawid M Sarwari, Preetesh Jain

¹From the University of Texas Health Science Center at Houston, Houston, TX.

Clinical Nuclear Medicine

|December 23, 2016

Summary

This summary is machine-generated.

Malignant eccrine spiradenoma, a rare skin cancer, presented as a rapidly growing groin mass in a 64-year-old man. Treatment involved extensive surgery, chemotherapy, and radiotherapy for this aggressive cancer.

More Related Videos

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

Related Experiment Videos

Last Updated: Mar 9, 2026

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

Area of Science:

Dermatology
Oncology

Background:

Malignant eccrine spiradenoma is an exceedingly rare appendageal neoplasm.
Early diagnosis and management are crucial for rare skin cancers.

Observation:

A 64-year-old male presented with a rapidly growing, 10-cm ulcerated groin mass over 6 months.
Positron emission tomography/computed tomography (PET/CT) revealed an intensely fluorodeoxyglucose (FDG)-avid lesion.

Findings:

Histopathology confirmed the diagnosis of malignant eccrine spiradenoma.
The patient underwent extensive tumor resection, chemotherapy, and radiotherapy.

Implications:

This case highlights the importance of considering rare skin cancers in the differential diagnosis of rapidly growing masses.
Multimodal treatment approaches are essential for managing malignant eccrine spiradenoma.
Further research into the pathogenesis and optimal treatment strategies for this rare malignancy is warranted.